Impact of candesartan on blood pressure variability and left ventricular hypertrophy in patients with essential hypertension
Zhang Jing-bao
Abstract
Zhang Jing-bao
Abstract
Objective To observe the impact of candesartan on blood pressure variability and left ventricular hypertrophy in patients with essential hypertension.Methods 72 cases of patients with essential hypertension treatment in our hospital from June 2011 to May 2012,to be given candesartan orally 12 weeks,were compared in blood pressure variability and left ventricular mass index changes before and after treatment.Results After 12 weeks of candesartan treatment,the variability of blood pressure in patients with essential hypertension significantly reduced(P0.05),and left ventricular mass index decreased significantly(P0.05).Conclusion Candesartan can reduce blood pressure variability and reverse left ventricular hypertrophy in patients with essential hypertension,which improve left ventricular function and prognosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the impact of candesartan on blood pressure variability and left ventricular hypertrophy in patients with essential hypertension.Methods 72 cases of patients with essential hypertension treatment in our hospital from June 2011 to May 2012,to be given candesartan orally 12 weeks,were compared in blood pressure variability and left ventricular mass index changes before and after treatment.Results After 12 weeks of candesartan treatment,the variability of blood pressure in patients with essential hypertension significantly reduced(P0.05),and left ventricular mass index decreased significantly(P0.05).Conclusion Candesartan can reduce blood pressure variability and reverse left ventricular hypertrophy in patients with essential hypertension,which improve left ventricular function and prognosis.
Key concepts: Candesartan, Medicine, Left ventricular hypertrophy, Essential hypertension, Blood pressure, Cardiology, Internal medicine, Muscle hypertrophy